Concepedia

Susan Moriarty

SM

Statistics

Publications

4

Citations

255

H-Index

4

Active since

2011

Affiliations

Eli Lilly (United States)(Current)

Swedish Medical Center

University of Toronto

University of Washington

Susan Moriarty is an author at Eli Lilly (United States) specializing in pharmacology, pharmacotherapy, and medicine.

Publications per year

2011–2018

4

Publications

4

Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)

Désirée van der Heijde, Dafna D. Gladman, Mitsumasa Kishimoto et al. · The Journal of Rheumatology · 2017 · 123 citations · Full text

, , +16

Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials

Philip J. Mease, Euthalia Roussou, Gerd R Burmester et al. · Arthritis Care & Research · 2018 · 67 citations · Full text

, , +15

A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

J. Carl Craft, Susan Moriarty, Kay Clark et al. · Clinical Infectious Diseases · 2011 · 46 citations · Full text

, , +13

<i>In vitro</i> Characterization of Oritavancin Clearance from Human Blood by Low-Flux, High-Flux, and Continuous Renal Replacement Therapy Dialyzers

Atul Kumar, Henry J. Mann, Mani Keshtgarpour et al. · The International Journal of Artificial Organs · 2011 · 19 citations

, , +17

1–4 of 4